Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Showing 1 to 23 of 23

TitleReference numberPublishedLast updated
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Depression in adults: treatment and managementNG222
Diroximel fumarate for treating relapsing–remitting multiple sclerosisTA794
Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiationTA798
Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal)TA797
Faricimab for treating diabetic macular oedemaTA799
Faricimab for treating wet age-related macular degenerationTA800
Filgotinib for treating moderately to severely active ulcerative colitisTA792
Gout: diagnosis and managementNG219
Ibrutinib for treating Waldenstrom's macroglobulinaemiaTA795
Multiple sclerosis in adults: managementNG220
Nerve graft for corneal denervationHTG629
Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancerTA801
Peristeen Plus transanal irrigation system for managing bowel dysfunctionHTG462
Preterm labour and birthNG25
Reducing sexually transmitted infectionsNG221
Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus)HTG627
Teduglutide for treating short bowel syndromeTA804
Thopaz+ portable digital system for managing chest drainsHTG465
Type 2 diabetes in adults: managementNG28
Venetoclax for treating chronic lymphocytic leukaemiaTA796
Vertebral body tethering for idiopathic scoliosis in children and young peopleHTG628

Results per page

  1. 10
  2. 25
  3. 50
  4. All